Combination therapy using interferon-.beta. and interleukin-2

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/103.1

A61K 38/21 (2006.01)

Patent

CA 1291706

Abstract of the Disclosure Anti-tumor activity in humans can be augmented by administering to the human patient an effective amount of IFN-.beta. and IL-2 in combination. The composition of IFN-.beta. and IL-2 may be prepared in vitro or administered separately to the patient. The composition is useful for prophylactic or therapeutic treatment of such cancers as melanoma, colon cancer, lung cancer and breast cancer.

531905

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy using interferon-.beta. and interleukin-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy using interferon-.beta. and interleukin-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using interferon-.beta. and interleukin-2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1244222

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.